Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and...
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is neutral on EV/EBITDA.
Target Price
The average target price of 6622.HK is 2.5 and suggests 26% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
Buy
Sell